Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Strain-specific induction of experimental autoimmune prostatitis (EAP) in mice.

Jackson CM, Flies DB, Mosse CA, Parwani A, Hipkiss EL, Drake CG.

Prostate. 2013 May;73(6):651-6. doi: 10.1002/pros.22606. Epub 2012 Nov 5.

2.

A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells.

Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC, Durham NM, Hipkiss EL, Pyle KJ, Wada S, Pan F, Pardoll DM, Drake CG.

Mol Immunol. 2010 Apr;47(7-8):1595-600. doi: 10.1016/j.molimm.2010.02.001. Epub 2010 Mar 11.

3.

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, Kwon EK, Muranski P, Restifo NP, Antony PA.

J Exp Med. 2010 Mar 15;207(3):651-67. doi: 10.1084/jem.20091921. Epub 2010 Feb 15.

4.

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG.

Cancer Res. 2009 May 15;69(10):4309-18. doi: 10.1158/0008-5472.CAN-08-4102. Epub 2009 May 12.

5.

Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.

Getnet D, Maris CH, Hipkiss EL, Grosso JF, Harris TJ, Yen HR, Bruno TC, Wada S, Adler A, Georgantas RW, Jie C, Goldberg MV, Pardoll DM, Drake CG.

J Immunol. 2009 Apr 15;182(8):4675-85. doi: 10.4049/jimmunol.0803400.

6.

Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.

Harris TJ, Hipkiss EL, Borzillary S, Wada S, Grosso JF, Yen HR, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, DeWeese TL, Drake CG.

Prostate. 2008 Sep 1;68(12):1319-29. doi: 10.1002/pros.20794.

7.

LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.

Grosso JF, Kelleher CC, Harris TJ, Maris CH, Hipkiss EL, De Marzo A, Anders R, Netto G, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, Drake CG.

J Clin Invest. 2007 Nov;117(11):3383-92.

8.

Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG.

J Immunol. 2007 Oct 1;179(7):4313-7.

9.

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA, Brockstedt DG, Dubensky TW Jr, Chen L, Pardoll DM, Drake CG.

Blood. 2007 Jul 1;110(1):186-92. Epub 2007 Mar 28.

10.

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ.

Cancer Cell. 2005 Mar;7(3):239-49.

11.

Role of LAG-3 in regulatory T cells.

Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA.

Immunity. 2004 Oct;21(4):503-13.

12.

Bacteriolytic therapy can generate a potent immune response against experimental tumors.

Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA Jr, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B.

Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15172-7. Epub 2004 Oct 7.

Supplemental Content

Loading ...
Support Center